MD Anderson Cancer Center
Cancer Research for Stage 1 Lung Cancer – CNL
New cancer research for stage 1 lung cancer is being investigated at The University of Texas MD Anderson Cancer Center. It’s led by Jack Roth, M.D., professor in the Department of Thoracic and Cardiovascular Surgery. This clinical trial called STARS (Stereotactic Radiation Therapy Verses Surgery) compares a new type of radiation treatment with a traditional surgery approach. Roth describes this promising new treatment and explains how lung cancer patients may get involved.

Transcript Transcript     Accessibility shortcut keys (H) Shortcuts
Loading the Audio Player...

Title: Cancer Research for Stage 1 Lung Cancer – CNL
Summary: New cancer research for stage 1 lung cancer is being investigated at The University of Texas MD Anderson Cancer Center. It’s led by Jack Roth, M.D., professor in the Department of Thoracic and Cardiovascular Surgery. This clinical trial called STARS (Stereotactic Radiation Therapy Verses Surgery) compares a new type of radiation treatment with a traditional surgery approach. Roth describes this promising new treatment and explains how lung cancer patients may get involved.
Keywords: lung cancer, lung, cancer, stage 1, stage one, early stage, research, cancer research, technology, clinical trial, roth, stars, Stereotactic Radiation Therapy Verses Surgery, radiation, stereotactic, therapy, surgery, options, thoracic, treatment, cnl, cancer newsline
Transcript: http://www.mdanderson.org/transcripts/cancer-newsline/2012/cancer-research-for-stage-1-lung-cancer-2-27-12.html